>_ QFI Terminal
Terminal › Stocks › MDCX

Medicus Pharma Ltd. Common Stock (MDCX) Stock

Healthcare · Biotechnology · CA
$0.10 -36.39%
Last updated Nov 12, 2026 10:46 UTC

MDCX Key Statistics

Market Cap$2.25M
P/E (TTM)-0.04
P/S (TTM)—
P/B (TTM)92.64
Revenue (TTM)$0.00
EPS (TTM)$-2.40
Dividend Yield—
ROE (TTM)-2,986.76%
Net Margin0.00%
Gross Margin0.00%
52W High$1.55
52W Low$0.09
Analyst ViewBuy
Price Target—
Employees12
Volume14,196,395

About Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

CEO: Raza Bokhari. Company website

MDCX — Frequently Asked Questions

What is the MDCX stock price today?

Medicus Pharma Ltd. Common Stock (MDCX) trades at $0.10, down 36.39% on the day, as of Nov 12, 2026 10:46 UTC.

What is Medicus Pharma Ltd. Common Stock's market cap?

Medicus Pharma Ltd. Common Stock has a market capitalisation of $2.25M, calculated from the live MDCX share price and shares outstanding.

What is the P/E ratio of MDCX?

MDCX has no meaningful price-to-earnings ratio: Medicus Pharma Ltd. Common Stock lost $2.40 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Medicus Pharma Ltd. Common Stock make?

Medicus Pharma Ltd. Common Stock generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for MDCX?

MDCX has traded between $0.09 and $1.55 over the past 52 weeks, and the last price is 93.4% below that high.

Is Medicus Pharma Ltd. Common Stock profitable?

Yes. Medicus Pharma Ltd. Common Stock keeps 0.00% of revenue as net income over the trailing twelve months.

What is the analyst price target for MDCX?

Wall Street analysts rate MDCX Buy.

What sector is Medicus Pharma Ltd. Common Stock in?

Medicus Pharma Ltd. Common Stock is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in CA .

Who is the CEO of Medicus Pharma Ltd. Common Stock?

Raza Bokhari is the chief executive of Medicus Pharma Ltd. Common Stock, which employs 12 people.

Where can I track MDCX in real time?

QFI Terminal shows MDCX with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See MDCX live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open MDCX in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc ARGX argenx SE GMAB Genmab A/S NBIX Neurocrine Biosciences, Inc. BMRN BioMarin Pharmaceutical Inc. UTHR United Therapeutics Corporation CDT CDT Equity Inc. MRNA Moderna, Inc. EXEL Exelixis, Inc. BNTX BioNTech SE SRPT Sarepta Therapeutics, Inc. HALO Halozyme Therapeutics, Inc. INSM Insmed Incorporated MDGL Madrigal Pharmaceuticals, Inc. TECH Bio-Techne Corporation ASND Ascendis Pharma A/S CAI Caris Life Sciences, Inc. IONS Ionis Pharmaceuticals, Inc. BBIO BridgeBio Pharma, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.